SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-19-002294
Filing Date
2019-01-22
Accepted
2019-01-22 16:54:04
Documents
1
Group Members
GARY J. MORGENTHALERGARY R. LITTLEHENRY PLAINJASON LETTMANNMORGENTHALER MANAGEMENT PARTNERS IX, LLCRALPH E. CHRISTOFFERSENREBECCA LYNNROBERT C. BELLAS, JR.ROBERT D. PAVEY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A tv511365_sc13da.htm SC 13D/A 156563
  Complete submission text file 0001144204-19-002294.txt   158361
Mailing Address 2710 SAND HILL ROAD SUITE 100 MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SUITE 100 MENLO PARK CA 94025 650-388-7600
MORGENTHALER VENTURE PARTNERS IX LP (Filed by) CIK: 0001439101 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Subject) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89680 | Film No.: 19535808
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1